These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 1104348)

  • 41. GnRH analogues for contraception.
    Fraser HM
    Br Med Bull; 1993 Jan; 49(1):62-72. PubMed ID: 8324616
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Post-coital contraceptive activity of crude extracts of Sri Lankan marine red algae.
    Ratnasooriya WD; Premakumara GA; Tillekeratne LM
    Contraception; 1994 Sep; 50(3):291-9. PubMed ID: 7805379
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Endometrial patterns in women on chronic luteinizing hormone-releasing hormone agonist treatment for contraception.
    Bergquist C; Nillius SJ; Wide L; Lindgren A
    Fertil Steril; 1981 Sep; 36(3):339-42. PubMed ID: 6793403
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Inhibition of ovulation during discontinuous intranasal luteinizing hormone-releasing hormone agonist dosing in combination with gestagen-induced bleeding.
    Lemay A; Faure N; Labrie F; Fazekas AT
    Fertil Steril; 1985 Jun; 43(6):868-77. PubMed ID: 3158551
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effects of various progestational preparations on gonadotropin secretion in ovariectomized immature female rats.
    McPherson JC; Costoff A; Eldridge JC; Mahesh VB
    Fertil Steril; 1974 Dec; 25(12):1063-70. PubMed ID: 4430386
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Sustained effects on synthetic ovarian steroids of rat myometrial contractility.
    Parkington HC; Lipton A
    J Endocrinol; 1976 Aug; 70(2):223-7. PubMed ID: 965882
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effect of T-shaped progesterone-releasing system on contraceptive efficacy and menstrual cycle regularity in Japanese monkeys.
    Oshima K; Hayashi M; Kato J
    Fertil Steril; 1976 May; 27(5):582-7. PubMed ID: 819310
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Anterior pituitary sensitivity in immature female rats stimulated with gonadotrophin releasing hormone in vivo: effect of priming with oestrogen, pregnant mare serum gonadotrophin or brain lesion.
    De Ziegler D; Wilkinson M; Cassard D; Ruf KB
    J Endocrinol; 1977 Jul; 74(1):99-109. PubMed ID: 327011
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Fertility regulation technology: status and prospects.
    Segal SJ; Nordberg OS
    Popul Bull; 1977 Mar; 31(6):1-25. PubMed ID: 12335682
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effect of levonorgestrel-releasing intrauterine device on hormonal profile and menstrual pattern after long-term use.
    Xiao B; Zeng T; Wu S; Sun H; Xiao N
    Contraception; 1995 Jun; 51(6):359-65. PubMed ID: 7554977
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Current status of antagonistic analogs of LH-RH as a contraceptive method in the female.
    Schally AV
    Res Front Fertil Regul; 1983 Jul; 2(5):1-16. PubMed ID: 12179624
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Luteolysis induced by a luteinizing hormone-releasing hormone agonist is prevented by human chorionic gonadotropin.
    Bergquist C; Nillius SJ; Wide L
    Contraception; 1980 Oct; 22(4):341-7. PubMed ID: 7004772
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Preclinical evaluation of norgestimate, a progestin with minimal androgenic activity.
    Phillips A; Hahn DW; McGuire JL
    Am J Obstet Gynecol; 1992 Oct; 167(4 Pt 2):1191-6. PubMed ID: 1415445
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Interaction of luteinizing hormone-releasing hormone, cyproterone acetate and arginine vasotocin on plasma levels of luteinizing hormone in intact and castrated adult male rats.
    Vaughan MK; Trakulrungsi C; Petterborg LJ; Johnson LY; Blask DE; Trakulrungsi W; Reiter RJ
    Mol Cell Endocrinol; 1979 Apr; 14(1):59-71. PubMed ID: 378736
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effect of anordiol on ovarian hormone secretion, ovulation, and uterine and vaginal responses in the immature rat.
    Lu YC; Chatterton RT
    Adv Contracept; 1994 Jun; 10(2):157-66. PubMed ID: 7942263
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Mode of action of dl-norgestrel and ethinylestradiol combination in postcoital contraception. II. Effect of postovulatory administration on ovarian function and endometrium.
    Ling WY; Wrixon W; Zayid I; Acorn T; Popat R; Wilson E
    Fertil Steril; 1983 Mar; 39(3):292-7. PubMed ID: 6402387
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Suppression of corpus luteum function by the gonadotropin-releasing hormone antagonist Nal-Glu: effect of the dose and timing of human chorionic gonadotropin administration.
    Dubourdieu S; Charbonnel B; Massai MR; Marraoui J; Spitz I; Bouchard P
    Fertil Steril; 1991 Sep; 56(3):440-5. PubMed ID: 1894021
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The effect of contraceptive steroids on hypothalamic-pituitary function.
    Mishell DR; Kletzky OA; Brenner PF; Roy S; Nicoloff J
    Am J Obstet Gynecol; 1977 May; 128(1):60-74. PubMed ID: 403765
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The mechanism of action of the copper intrauterine device.
    Tamaya T; Nakata Y; Ohno Y; Nioka S; Furuta N
    Fertil Steril; 1976 Jul; 27(7):767-72. PubMed ID: 181276
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prolonged combined in vivo pre-treatment with luteinizing hormone-releasing hormone (LRH) and oestradiol benzoate causes long-lasting suppression of the autonomous and the LRH-stimulated secretion of luteinizing hormone and follicle stimulating hormone. An in vitro study.
    Schuiling GA; Moes H; Koiter TR
    Acta Endocrinol (Copenh); 1984 Apr; 105(4):468-73. PubMed ID: 6426227
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.